Literature DB >> 15064741

Ras is involved in the negative control of autophagy through the class I PI3-kinase.

Shuichi Furuta1, Eiko Hidaka, Aya Ogata, Sadaki Yokota, Tohru Kamata.   

Abstract

Ras proteins exert a pivotal regulatory function in signal transduction involved in cell proliferation and their activation mutation leads to malignant cell transformation. However, the role of Ras proteins in autophagy, an intracellular protein degradation process in cell growth control is unknown. In the present study, we demonstrate that the degradation of long-lived proteins in NIH3T3 cells in response to nutrient starvation was significantly suppressed by oncogenic RasVal12 transformation in a rapamycin (mTOR inhibitor)-sensitive manner. Morphologic observations also show the decrease in the formation of autophagic vacuoles upon the Ras transformation. Furthermore, epidermal growth factor or serum downregulated the protein degradation induced by serum starvation and the dominant-negative RasAsn17 mutant counteracted this suppressive effect, indicating that Ras mediates the growth factor downregulation of autophagy. The suppression of protein degradation by the activated RasVal12 was mediated by the class I phosphatidyl inositol 3-kinase (PI3-kinase), but not either or Raf Ral GDS. Consistent with this, RasVal12 and class I PI3-kinase inhibited the rate of autophagic sequestration of LDH. These data suggest that Ras plays a critical role as a negative regulator for nutrient deprivation-induced autophagy through the class I PI3-kinase signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064741     DOI: 10.1038/sj.onc.1207539

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

Review 1.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

2.  Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Da-En Cheng; Wei-Kai Chen; Cheng-Huang Shen; Ying-Ray Lee; Roberto Zuchini; Hsiao-Sheng Liu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

3.  The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.

Authors:  Kaustuv Sahoo; Mikhail G Dozmorov; Shrikant Anant; Vibhudutta Awasthi
Journal:  Invest New Drugs       Date:  2010-12-22       Impact factor: 3.850

4.  The molecular machinery of autophagy: unanswered questions.

Authors:  Daniel J Klionsky
Journal:  J Cell Sci       Date:  2005-01-01       Impact factor: 5.285

5.  The ARF tumor suppressor can promote the progression of some tumors.

Authors:  Olivier Humbey; Julia Pimkina; Jack T Zilfou; Michal Jarnik; Carmen Dominguez-Brauer; Darren J Burgess; Christine M Eischen; Maureen E Murphy
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

6.  BRAF V600E-dependent role of autophagy in uveal melanoma.

Authors:  Yinu Zhao; Weibin Wang; Irene Min; Brian Wyrwas; Maureen Moore; Rasa Zarnegar; Thomas J Fahey
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-07       Impact factor: 4.553

Review 7.  Mechanisms of oncogene-induced genomic instability.

Authors:  Simona Graziano; Susana Gonzalo
Journal:  Biophys Chem       Date:  2016-11-24       Impact factor: 2.352

8.  Autophagic activity dictates the cellular response to oncogenic RAS.

Authors:  Yihua Wang; Xiao Dan Wang; Eleonora Lapi; Alexandra Sullivan; Wei Jia; You-Wen He; Indrika Ratnayaka; Shan Zhong; Robert D Goldin; Christoph G Goemans; Aviva M Tolkovsky; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

Review 9.  Autophagy and tumorigenesis.

Authors:  Srirupa Roy; Jayanta Debnath
Journal:  Semin Immunopathol       Date:  2010-06-30       Impact factor: 9.623

10.  The role of autophagy in tumour development and cancer therapy.

Authors:  Mathias T Rosenfeldt; Kevin M Ryan
Journal:  Expert Rev Mol Med       Date:  2009-12-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.